ECSP056077A - Composición de insulina oral y métodos de fabricación y uso de estos - Google Patents

Composición de insulina oral y métodos de fabricación y uso de estos

Info

Publication number
ECSP056077A
ECSP056077A EC2005006077A ECSP056077A ECSP056077A EC SP056077 A ECSP056077 A EC SP056077A EC 2005006077 A EC2005006077 A EC 2005006077A EC SP056077 A ECSP056077 A EC SP056077A EC SP056077 A ECSP056077 A EC SP056077A
Authority
EC
Ecuador
Prior art keywords
composition
manufacture
methods
mammal
oral insulin
Prior art date
Application number
EC2005006077A
Other languages
English (en)
Inventor
Vladimir Sabetsky
Original Assignee
Technology Dev Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technology Dev Company filed Critical Technology Dev Company
Publication of ECSP056077A publication Critical patent/ECSP056077A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Un método para reducir la glucosa sanguínea en un mamífero incluye administrar oralmente una cantidad terapéuticamente efectiva de micropartículas de dextrán cristalizada e insulina al mamífero para reducir la glucosa sanguínea del mamífero. La composición puede ser una fase o una composición multi-fase estructurada para liberación controlada de insulina.
EC2005006077A 2003-03-04 2005-10-04 Composición de insulina oral y métodos de fabricación y uso de estos ECSP056077A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45124503P 2003-03-04 2003-03-04
US46760103P 2003-05-05 2003-05-05
US46901703P 2003-05-09 2003-05-09
US49509703P 2003-08-15 2003-08-15

Publications (1)

Publication Number Publication Date
ECSP056077A true ECSP056077A (es) 2006-08-30

Family

ID=32831112

Family Applications (3)

Application Number Title Priority Date Filing Date
EC2005006078A ECSP056078A (es) 2003-03-04 2005-10-04 Composición de insulina inyectable de acción prolongada y métodos de fabricación y uso del mismo
EC2005006077A ECSP056077A (es) 2003-03-04 2005-10-04 Composición de insulina oral y métodos de fabricación y uso de estos
EC2005006076A ECSP056076A (es) 2003-03-04 2005-10-04 Sistema de suministro para droga y terapia celular

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EC2005006078A ECSP056078A (es) 2003-03-04 2005-10-04 Composición de insulina inyectable de acción prolongada y métodos de fabricación y uso del mismo

Family Applications After (1)

Application Number Title Priority Date Filing Date
EC2005006076A ECSP056076A (es) 2003-03-04 2005-10-04 Sistema de suministro para droga y terapia celular

Country Status (17)

Country Link
US (5) US20040234615A1 (es)
EP (3) EP1603589A1 (es)
JP (3) JP2006519252A (es)
KR (3) KR20060015469A (es)
AR (1) AR046485A1 (es)
AT (1) ATE485051T1 (es)
AU (3) AU2004216908A1 (es)
BR (3) BRPI0408105A (es)
CA (3) CA2518136A1 (es)
DE (1) DE602004029630D1 (es)
EA (3) EA200501422A1 (es)
EC (3) ECSP056078A (es)
MX (1) MXPA05009493A (es)
NO (3) NO20054533L (es)
PT (1) PT1454630E (es)
TW (1) TW200529869A (es)
WO (3) WO2004078198A1 (es)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166132A1 (en) * 1998-08-26 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
BRPI0408105A (pt) * 2003-03-04 2006-03-01 Thetechnology Dev Company Ltd sistema de distribuição para droga e terapia celular
CA2531988C (en) 2003-08-05 2016-06-28 Novo Nordisk A/S Novel insulin derivatives
TW200603843A (en) * 2004-04-20 2006-02-01 Technology Dev Company Ltd Tissue enhancement implant and method
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
KR101644250B1 (ko) 2004-08-23 2016-07-29 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
FR2880272A1 (fr) * 2005-01-04 2006-07-07 Jean Marc Ruiz Preparation contenant des microparticules d'un sel de polymere insoluble portant un principe actif, ainsi que son procede de fabrication
US8932633B2 (en) * 2005-08-29 2015-01-13 Biopharm Solutions Inc. Polysaccharide microparticles containing biological agents: their preparation and applications
CN104324362B (zh) 2005-09-14 2018-04-24 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
ES2371361T3 (es) * 2005-12-28 2011-12-30 Novo Nordisk A/S Composiciones que comprenden una insulina acilada y zinc y método de producción de dichas composiciones.
SE529040C2 (sv) * 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin
IN2015DN00888A (es) 2006-02-22 2015-07-10 Mannkind Corp
EP2069062A2 (en) * 2006-10-06 2009-06-17 The President and Fellows of Harvard College Chemically-directed electrostatic self-assembly of materials
JP5552046B2 (ja) 2007-06-13 2014-07-16 ノボ・ノルデイスク・エー／エス インスリン誘導体を含有する薬学的製剤
EP2025334A1 (en) * 2007-07-25 2009-02-18 OctoPlus Sciences B.V. Sustained release drug delivery system for repeated administration
ES2929343T3 (es) 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
FR2940802A1 (fr) * 2008-10-10 2010-07-09 Adocia Complexe entre l'insuline humaine et un polymere amphiphile et utilisation de ce complexe pour la preparation d'une formulation d'insuline humaine rapide.
RS59913B1 (sr) 2008-10-17 2020-03-31 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
JP4959005B2 (ja) 2008-10-30 2012-06-20 ノボ・ノルデイスク・エー／エス 毎日の注射頻度より少ないインスリン注射での真性糖尿病の治療
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
FR2943538B1 (fr) * 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
CN104721825B (zh) 2009-06-12 2019-04-12 曼金德公司 具有确定比表面积的二酮哌嗪颗粒
CN102596175A (zh) 2009-07-06 2012-07-18 赛诺菲-安万特德国有限公司 含有甲硫氨酸的水性胰岛素制备物
US9068182B2 (en) * 2009-07-28 2015-06-30 Corning Incorporated Synthetic polysaccharide microcarriers for culturing cells
HUP0900482A2 (en) 2009-08-03 2011-03-28 Cera Med Kft Pharmaceutical formulation for oral administration
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
MY180661A (en) 2009-11-13 2020-12-04 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
PT3345593T (pt) 2009-11-13 2023-11-27 Sanofi Aventis Deutschland Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
PL2611458T3 (pl) 2010-08-30 2017-02-28 Sanofi-Aventis Deutschland Gmbh Zastosowanie AVE0010 do produkcji leku do leczenia cukrzycy typu 2
DK2632478T3 (da) 2010-10-27 2019-10-07 Novo Nordisk As Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller
AU2012236150B2 (en) 2011-04-01 2016-03-31 Mannkind Corporation Blister package for pharmaceutical cartridges
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
US10143754B2 (en) * 2011-08-07 2018-12-04 Transgene Biotek Limited Method for peroral delivery of insulin and its analogues for therapeutic usage
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
CN104619369B (zh) 2012-07-12 2018-01-30 曼金德公司 干粉药物输送系统和方法
US9157939B2 (en) * 2012-08-09 2015-10-13 Infineon Technologies Ag System and device for determining electric voltages
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
CN104902922B (zh) 2012-11-13 2017-12-12 阿道恰公司 包含经取代阴离子化合物的速效胰岛素制剂
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
UA117480C2 (uk) 2013-04-03 2018-08-10 Санофі Лікування цукрового діабету за допомогою складу інсуліну тривалої дії
EP2991672A1 (en) 2013-04-30 2016-03-09 Novo Nordisk A/S Novel administration regime
JP6200698B2 (ja) * 2013-06-18 2017-09-20 ニュートリー株式会社 嚥下造影検査食
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
RU2014120626A (ru) * 2014-05-22 2015-11-27 Владимир Андреевич Сабецкий Инсулинсодержащий препарат пролонгированного действия
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN105617362B (zh) * 2014-10-27 2021-05-11 中国医学科学院药物研究所 一种新型的胰岛素－磷脂－壳聚糖自组装微粒载体及其制剂
EP3229828B1 (en) 2014-12-12 2023-04-05 Sanofi-Aventis Deutschland GmbH Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
WO2017141262A1 (en) 2016-02-19 2017-08-24 Indian Institute Of Technology, Bombay Orally administrable pharmaceutical preparation containing protein
RU2647466C1 (ru) * 2016-12-01 2018-03-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный университет" (СПбГУ) Способ получения нативного белка пролонгирующего действия в составе полимерных наносфер и резорбируемых микросфер для доставки
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
US12343383B2 (en) 2019-07-12 2025-07-01 Novo Nordisk A/S High concentration insulin formulation
KR20200056360A (ko) 2020-04-29 2020-05-22 김용원 자전거바퀴(회전자)와 바퀴덮개(고정자)에 설치하는 발전기
KR20200056359A (ko) 2020-04-29 2020-05-22 김용원 퀵보드 등 승용기구바퀴(회전자)에 설치되는 바퀴덮개(고정자)에 설치하는 발전기
KR20200056361A (ko) 2020-05-04 2020-05-22 김용원 발판보드에 설치하는 발전기
KR20200060307A (ko) 2020-05-06 2020-05-29 김용원 자전거와 리어 캐리어에 설치하는 발전장치들
KR20200060308A (ko) 2020-05-07 2020-05-29 김용원 수상보드에 설치하는 발전기
KR20200060309A (ko) 2020-05-08 2020-05-29 김용원 헬스차량에 설치하는 발전기
KR20200062092A (ko) 2020-05-11 2020-06-03 김용원 수차와 공기 컴프레서를 이용한 공기 터빈구조 발전기와 바퀴구조 발전기를 합한 발전기
KR20200061324A (ko) 2020-05-11 2020-06-02 김용원 보트에 설치하는 발전기
KR20200068614A (ko) 2020-05-26 2020-06-15 김용원 펠티어소자를 이용한 공기, 물 컨디션너 조절장치 내에 설치한 발전기
KR20200083393A (ko) 2020-06-16 2020-07-08 김용원 "공기 터빈구조 발전기"와 "바퀴구조를 합한 발전기"를 "발열소자를 이용한 발전기"와 적용 양방향 모터(양방향 프로펠러)를 양방향공기추진기(Propullor)와 결합 장착한 드론
KR20200088241A (ko) 2020-06-30 2020-07-22 김용원 역방향 모터(양방향 프로펠러)의 추진에 맞는 관성을 이기는 팬이 없는 양방향공기추진기(Propullor)를 장착한 드론
KR20200108392A (ko) 2020-08-31 2020-09-18 김용원 전동 오토바이 모터의 정격에 맞는 오토바이바퀴에 회전자와 물받이 고정자 발전기를 설치한 오토바이에 모터가 장착된 항공기 공기추진기(Propulsor)와 장착한 드론의 프로퓰러(Propullor)를 장착하는 제조기술)
WO2022149125A1 (en) * 2021-01-07 2022-07-14 Ramot At Tel Aviv University Ltd. Methods and compositions for melanin synthesis
KR20210018367A (ko) 2021-01-26 2021-02-17 김용원 전동 오토바이에 설치한 모터가 장착된 항공기 공기추진기와 장착한 프로퓰러(Propullor)로 구성한 오토에어크라프트(Autoaircraft)
KR20210029730A (ko) 2021-02-22 2021-03-16 김용원 산사태에 대비, 대응하는 에어 레이어들 블록들이 형성된 거대장비들(에어 레이어들 블록들)
KR20210040852A (ko) 2021-03-24 2021-04-14 김용원 전동에어버스
KR20210043513A (ko) 2021-03-26 2021-04-21 김용원 전동에어버스에 설치하는 연기(분연), 재 포집장치
KR20210045369A (ko) 2021-03-31 2021-04-26 김용원 전기 에어 카
KR20210049046A (ko) 2021-04-13 2021-05-04 김용원 전기에어버스를 강풍, 태풍에 구조하는 보조날개와 보조출입문 장치
KR20210055643A (ko) 2021-04-27 2021-05-17 김용원 모터가 장착된 회전축에 다량의 회전자바퀴와 다량의 고정자바퀴발전기를 설치한 전동보드
KR20210072739A (ko) 2021-05-27 2021-06-17 김용원 의료용 전동보드
KR20210080293A (ko) 2021-06-11 2021-06-30 김용원 바퀴 사이 발전기 케이스
CN115702880B (zh) * 2021-08-12 2023-11-03 山东新时代药业有限公司 一种重组甘精胰岛素注射液及其制备工艺
KR20220016234A (ko) 2022-01-14 2022-02-08 김용원 공기추진기(공기펌프와 공기터빈)를 장착한 3륜 자전거
KR20220038026A (ko) 2022-02-24 2022-03-25 김용원 4합 공기터빈 : 공기터빈 축에 1. 인너 팬들의 인너 실린더와 2. 아웃터 팬들의 아웃터 실린더와 3. 양쪽 1. 인너 실린더들과 2. 아웃터 실린더들의 사이에 아웃터 팬들에 덕트팬들과 덕트흡입구와 4 1. 인너 실린더들과 2. 아웃터 실린더들의 사이에 아웃터 팬들의 3. 덕트팬들에 블레이드와 블레이드 외부 형틀
KR20220056159A (ko) 2022-04-04 2022-05-04 김용원 물탱크 내의 스팀집 슈퍼히터에 전력공급한 스팀공급으로 스팀터빈을 구동하는 것과 슈퍼히터로 스팀을 공급하는 스팀청소기에 발전기들을 설치하는 것과 공기터빈의 흡입구들의 공기필터들 설치와 펠티에소자를 이용한 냉온 공기배출과 얼음제조기 시스템
KR20220056835A (ko) 2022-04-18 2022-05-06 김용원 공기추진기(공기펌프와 여러 공기터빈들)들을 장착한 수상 자전거
KR20220076421A (ko) 2022-05-11 2022-06-08 김용원 공기추진기(공기펌프와 공기터빈들)들을 장착한 페달자전차
KR20220080053A (ko) 2022-05-27 2022-06-14 김용원 다중 에어 레이어 튜브보트
KR20240124226A (ko) * 2023-02-08 2024-08-16 주식회사 인벤테라 체내 구조물 사이에서 응집없이 압축가능한 다당류 가교 콜로이드 입자 및 이의 생체내 주입용 개질제로서의 용도
KR20250070006A (ko) 2025-04-23 2025-05-20 김용원 수륙양용 전동보드

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
SE8204244L (sv) * 1982-07-09 1984-01-10 Ulf Schroder Kristalliserad kolhydratsmatris for biologiskt aktiva substanser
US4963526A (en) * 1984-05-09 1990-10-16 Synthetic Blood Corporation Oral insulin and a method of making the same
WO1987002704A1 (en) * 1985-10-22 1987-05-07 Eric Robinson Process for cell immobilisation
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
USRE37950E1 (en) 1990-04-24 2002-12-31 Atrix Laboratories Biogradable in-situ forming implants and methods of producing the same
US5618531A (en) 1990-10-19 1997-04-08 New York University Method for increasing the viability of cells which are administered to the brain or spinal cord
US5840290A (en) * 1996-05-30 1998-11-24 University Of Florida Research Foundation Injectable bio-active glass in a dextran suspension
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6395302B1 (en) 1996-11-19 2002-05-28 Octoplus B.V. Method for the preparation of microspheres which contain colloidal systems
EP0941068B1 (en) * 1996-11-19 2004-05-26 OctoPlus B.V. Controlled release microspheres
EP0842657A1 (en) 1996-11-19 1998-05-20 OctoPlus B.V. Microspheres for controlled release and processes to prepare these microspheres
FR2764514B1 (fr) * 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
BR9810693A (pt) 1997-07-10 2000-08-15 Usbiomaterials Corp Composição bioativa moldável, composição farmacêutica biocompatìvel, e, processos para reparo, substituição, reconfiguração, reconstrução ou aumento de estruturas anatÈmicas de tecido duro e para induzir osteogênese
US6194006B1 (en) * 1998-12-30 2001-02-27 Alkermes Controlled Therapeutics Inc. Ii Preparation of microparticles having a selected release profile
US20020054914A1 (en) 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
WO2000048576A1 (en) * 1999-02-19 2000-08-24 Universiteit Utrecht Stereocomplex hydrogels
FR2794649B1 (fr) * 1999-06-11 2003-04-11 Solutions Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
CA2385887A1 (en) * 1999-09-27 2001-04-05 John C. Lee Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
EP1184032A1 (en) * 2000-08-31 2002-03-06 OctoPlus B.V. Dextran hydrogels
FR2814951B1 (fr) 2000-10-06 2003-01-17 Flamel Tech Sa Suspension colloidale de particules submicroniques de vectorisation de principes actifs hydrophiles (insuline) et leur mode de preparation
CA2429100A1 (en) 2000-11-16 2002-05-23 Jagotec Ag Parenterally administrable microparticles
WO2002067995A1 (en) 2001-02-26 2002-09-06 Council Of Scientific And Industrial Research Carrier systems comprising vitamin b12 - biodegradable micro particulate conju gates for peroral delivery of drugs, peptides/proteins and vaccines
NZ519403A (en) * 2001-06-21 2005-03-24 Pfizer Prod Inc Use of insulin in a medicament to reduce weight gain in a diabetic patient who is using exogenous insulin to control blood sugar levels
BRPI0408105A (pt) * 2003-03-04 2006-03-01 Thetechnology Dev Company Ltd sistema de distribuição para droga e terapia celular
SE529040C2 (sv) * 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin

Also Published As

Publication number Publication date
ECSP056076A (es) 2006-08-30
US20100167985A1 (en) 2010-07-01
EA200501420A1 (ru) 2006-04-28
BRPI0408105A (pt) 2006-03-01
NO20054533D0 (no) 2005-10-03
WO2004078198A1 (en) 2004-09-16
JP2006519252A (ja) 2006-08-24
US7544656B2 (en) 2009-06-09
BRPI0408100A (pt) 2006-03-01
US20040234616A1 (en) 2004-11-25
JP2006519840A (ja) 2006-08-31
NO20054534L (no) 2005-11-29
BRPI0408097A (pt) 2006-02-14
TW200529869A (en) 2005-09-16
EA200501421A1 (ru) 2006-04-28
NO20054539L (no) 2005-12-01
US20100166855A1 (en) 2010-07-01
EA200501422A1 (ru) 2006-04-28
KR20060014027A (ko) 2006-02-14
AU2004216911A1 (en) 2004-09-16
CA2518136A1 (en) 2004-09-16
EP1603589A1 (en) 2005-12-14
AU2004216908A1 (en) 2004-09-16
NO20054533L (no) 2005-12-02
AR046485A1 (es) 2005-12-14
WO2004078197A1 (en) 2004-09-16
EP1454630B1 (en) 2010-10-20
AU2004216909A1 (en) 2004-09-16
WO2004078196A1 (en) 2004-09-16
EP1454630A1 (en) 2004-09-08
JP2006519253A (ja) 2006-08-24
NO20054539D0 (no) 2005-10-03
DE602004029630D1 (de) 2010-12-02
EP1454631A1 (en) 2004-09-08
NO20054534D0 (no) 2005-10-03
US20040234615A1 (en) 2004-11-25
ATE485051T1 (de) 2010-11-15
MXPA05009493A (es) 2006-08-11
KR20060015472A (ko) 2006-02-17
CA2518148A1 (en) 2004-09-16
CA2518143A1 (en) 2004-09-16
KR20060015469A (ko) 2006-02-17
US20110097385A1 (en) 2011-04-28
ECSP056078A (es) 2006-08-30
PT1454630E (pt) 2010-12-15

Similar Documents

Publication Publication Date Title
ECSP056077A (es) Composición de insulina oral y métodos de fabricación y uso de estos
EE200300171A (et) Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks
FR2878159B1 (fr) Medicament oral a liberation modifiee d'au moins un principe actif sous forme multimicrocapsulaire
AR034900A1 (es) Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica
CL2007003609A1 (es) Compuestos derivados de dihidropiridinas sustituidas; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; proceso para producir la composicion farmaceutica; y uso en el tratamiento de una enfermedad mejorada con la inhibicion
CY2016031I2 (el) Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων
AR068185A1 (es) Composiciones de tabletas de desintegracion oral de lamotrigina
EE05316B1 (et) Kristalliline antikolinergikum, meetod selle valmistamiseks ja selle kasutamine ravimi valmistamiseks
AR052854A1 (es) Metodo para reducir la inflamacion del tejido oral utilizando extracto de magnolia
MXPA05012350A (es) Antagonistas rage como agentes para la amiloidosis inversa y enfermedades asociadas con la misma.
NI200800169A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento del dolor
ECSP10010052A (es) Formulaciones galenicas de alisquireno y valsartan
AR065581A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
JP2005507892A5 (es)
EP1781277A4 (en) COMBINATION PREPARATION
EA200702102A1 (ru) Пластинки, содержащие стероидные гормоны
AR022621A1 (es) Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina
ITMI20021866A1 (it) Preparazione farmaceutica in forma colloidale utile nella cura delle affezioni cutanee.
CR8059A (es) Composicion farmaceutica en forma de hidrogel para administracion transdermica de sustancias activas
PL1778209T3 (pl) Sposoby i kompozycje do doustnego dostarczania FTS
RU2007138263A (ru) Противовоспалительные соединения
MX2007005348A (es) Formas amorfas y polimorficas de sodio de telmisartan.
CO6410284A2 (es) Composición farmacéutica oral para uso en enfermedades respiratorias
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12
WO2004069272A3 (en) Adjuvant combination for use in the immunization of a mamal comprising il2 and il12